業績集（令和5年4月～令和6年3月）

 

Ⅰ　原　　　著

英文原著

1.Ito Y, Ozawa H, Eto T, Miyamoto T, Kamimura T, Ogawa R, Uchida N, Wake A, Fujisaki T, Ohno Y, Takase K, Okumura H, Takamatsu Y, Kawano N, Akashi K, Nagafuji K.

IKZF1plus alterations are not associated with outcomes in Philadelphia-positive acute lymphoblastic leukemia patients enrolled in the FBMTG ALL/MRD2008 trial.
Eur J Haemtol 111, 103-112, 2023

2.Sakoda T, Kikushige Y, Miyamoto T, Irifune H, Harada T, Hatakeyama K, Kunisaki Y, Kato K, Akashi K.

TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia.
Blood Adv 7, 2053-2065, 2023

3.Irifune H, Kochi Y, Miyamoto T, Sakoda T, Kato K, Kunisaki Y, Akashi K, Kikushige Y.

GPAM mediated lysophosphatidic acid synthesis regulates mitochondrial dynamics in acute myeloid leukemia.
Cancer Sci 114, 3247-3258, 2023

4.Harada T, Kikushige Y, Miyamoto T, Uno K, Niiro H, Kawakami A, Koga T, Akashi K, Yoshizaki K.
Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease.
Nat Commun 14, 6959, 2023


5.Mori Y, Uchida N, Wake A, Miyawaki K, Eto T, Nakamura T, Iwasaki H, Ito Y, Tanimoto K, Katayama Y, Imamura Y, Takahashi T, Fujisaki T, Kamimura T, Choi I, Ishitsuka K, Yoshimoto G, Ogawa R, Sugita J, Takamatsu Y, Tanimoto K, Hidaka T, Miyamoto T, Akashi K, Nagafuji K.

Impact of a third dose of anti-SARS-CoV-2 vaccine in hematopoietic cell transplant recipients: A Japanese multicenter observational study.
Vaccine 41, 6899-6903, 2023

6.Katsuya H, Yamaguchi K, Dung TC, Sano H, Itamura H, Okamoto S, Yoshimura M, Ureshino H, Ando T, Zaimoku Y, Nakao S, Kimura S

Late graft failure with donor-derived GPI-deficient cells in a mixed chimera following allogeneic bone marrow transplantation for severe aplastic anemia.
Bone Marrow Transplant 58(4):465-468. 2023

7.Imai Y, Nagaya S, Araiso Y, Meguro-Horike M, Togashi T, Ohmori K, Makita Y, Sato E, Yujiri T, Nagamori Y, Horike SI, Watanabe A, Morishita E.

Identification and functional analysis of three novel genetic variants resulting in premature termination codons in three unrelated patients with hereditary antithrombin deficiency.
Int J Hematol. 117(4):523-529. 2023

8.Kanda Y, Usuki K, Inagaki M, Ohta A, Ogasawara Y, Obara N, Kako S, Kurokawa M, Shimada N, Suzuki T, Hama A, Yamaguchi H, Nakao S, Yamazaki H.

Decision analysis of allogeneic bone marrow transplantation versus immunosuppressive therapy for young adult patients with aplastic anemia.
Int J Hematol;117(5):660-668. 2023

9.Nakamura Y, Mori T, Kako S, Yamazaki H, Kanda Y, Uchida N, Tanaka M, Nawa Y, Fukuda T, Ichinohe T, Atsuta Y, Onishi Y.

Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia
Int J Hematol;117(3):356-365. 2023

10.Imi T, Mizumaki H, Hosomichi K, Nannya Y, Zaimoku Y, Yoroidaka T, Katagiri T, Ishiyama K, Yamazaki H, Ogawa R, Kuroiwa M, Tajima A, Ogawa S, Nakao S.

Familial immune-mediated aplastic anaemia in six different families.
EJHaem. Jun 28;4(3):714-718. 2023

11.Nishiwaki S, Sugiura I, Fujisawa S, Hatta Y, Atsuta Y, Doki N, Kurahashi S, Ueda Y, Dobashi N, Maeda T, Taniguchi Y, Tanaka M, Kako S, Ichinohe T, Fukuda T, Ohtake S, Ishikawa Y, Kiyoi H, Matsumura I, Miyazaki Y.

High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI-SCT Study.
Hemasphere. 7(6):e899. 2023

12.Nagaya S, Togashi T, Akiyama M, Imai Y, Matsumoto H, Moriya H, Meguro-Horike M, Yasuda I, Kikuchi Y, Kuwajima Y, Horike SI, Watanabe A, Morishita E

Protein S deficiency caused by cryptic splicing due to the novel intron variant c.346+5G>C in PROS1.
Thromb Res. 24;229:26-30. 2023

13.Nagao A, Tokugawa T, Matsuo Y, Shirayama R, Morishita E, Nozima M, Kinai E, Nishida Y, Fukutake K.

The length of the sanitary napkins can be used as a handier index than pictorial blood loss assessment chart to predict the heavy menstrual bleeding.
J Obstet Gynaecol Res. 49(7):1838-1845. 2023

14.Nannya Y, Tobiasson M, Sato S, Bernard E, Ohtake S, Takeda J, Creignou M, Zhao L, Kusakabe M, Shibata Y, Nakamura N, Watanabe M, Hiramoto N, Shiozawa Y, Shiraishi Y, Tanaka H, Yoshida K, Kakiuchi N, Makishima H, Nakagawa M, Usuki K, Watanabe M, Imada K, Handa H, Taguchi M, Kiguchi T, Ohyashiki K, Ishikawa T, Takaori-Kondo A, Tsurumi H, Kasahara S, Chiba S, Naoe T, Miyano S, Papaemanuil E, Miyazaki Y, Hellstrom-Lindberg E, Ogawa S.

Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms.
Blood Adv. 25;7(14):3624-3636. 2023

15.Sunami K, Fuchida SI, Suzuki K, Ri M, Matsumoto M, Shimazaki C, Asaoku H, Shibayama H, Ishizawa K, Takamatsu H, Ikeda T, Maruyama D, Imada K, Uchiyama M, Kiguchi T, Iyama S, Murakami H, Onishi R, Tada K, Iida S.

Anti-CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study.
Hematol Oncol. 41(3):442-452. 2023

16.Tani H, Inasaki N, Yazawa S, Shimada T, Saga Y, Kaya H, Maruyama Y, Matano S, Itoh H, Kashii T, Yamazaki E, Itamochi M, Oishi K.

Neutralizing Antibody Levels and Epidemiological Characteristics of Patients with Breakthrough COVID-19 Infection in Toyama, Japan.
Jpn J Infect Dis. 2023 Sep 22;76(5):319-322.

17.Imai Y, Nagaya S, Araiso Y, Meguro-Horike M, Togashi T, Horike S, Kawasaki H, Morishita E.

Functional analysis of two abnormal antithrombin proteins with different intracellular kinetics.
Thromb Res.230:18-26 2023

18.Nakanuma S, Gabata R, Okazaki M, Seki A, Hosokawa K, Yokoyama T, Katano K, Sugita H, Tokoro T, Takada S, Makino I, Taniguchi T, Harada K, Yagi S.

Hemophagocytic Lymphohistiocytosis With Elevated Cytokines Related to Macrophage Activation After Liver Transplantation for Autoimmune Hepatitis: A Case Report.
Transplant Proc. 2023 Oct;55(8):1946-1950. 

19.Ishiyama K, Yonemura Y, Kawaguchi T, Hosokawa K, Sugimori C, Ueda Y, Takamori H, Obara N, Noji H, Shirasugi Y, Ando K, Shichishima T, Ninomiya H, Chiba S, Nishimura JI, Kanakura Y, Nakao S.

A longitudinal analysis of paroxysmal nocturnal haemoglobinuria-type cells in patients with bone marrow failure: Results of a prospective multi-centre study in Japan.
Br J Haematol. 2023 Nov;203(3):468-476

20.Mizumaki H, Tran DC, Hosokawa K, Hosomichi K, Zaimoku Y, Takamatsu H, Yamazaki H, Ishiyama K, Yamazaki R, Fujiwara H, Tajima A, Nakao S

Minor GPI(-) granulocyte populations in aplastic anemia and healthy individuals derived from a few PIGA-mutated hematopoietic stem progenitor cells.
Blood Cancer J 13(1):165. 2023

21.Takamatsu H, Matsuda T, Mizuno S, Takahashi T, Fuchida SI, Hanamura I, Kataoka K, Tsukada N, Matsumoto M, Hangaishi A, Doki N, Uchida N, Sawa M, Maruyama Y, Kurahashi S, Nagafuji K, Harazaki Y, Kako S, Iida S, Ichinohe T, Kanda Y, Atsuta Y, Sunami K.

Multiple Myeloma Working Group in the Japanese Society for Transplantation and Cellular Therapy. Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs.Haematologica.108(12):3399-3408 2023

22.Onishi Y, Mori T, Yamazaki H, Hiramoto N, Zaimoku Y, Kanaya M, Matsue K, Onizuka M, Aotsuka N, Uchida N, Onodera K, Kanda J, Nakamae H, Yamamoto R, Kuriyama T, Kimura T, Ichinohe T, Atsuta Y

Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia
Transplant Cell Ther 29(12):766.e1-766.e8. 2023

23.St Germain L, De Paula E, Ay C, Barco S, Cesarman-Maus G, Connors JM, Dumantepe M, Cecilia Guillermo Esposito M, Lee LH, Morishita E, Samama CM, Okoye H, Robertson T, McPherson G, Castellucci LA.

Moving against thrombosis: ISTH recognizes 10th anniversary of World Thrombosis Day and the leaders in the field who led the way - in memory of Claire McLintock, MD, World Thrombosis Day Steering Committee Vice Chair 2019 to 2022.
J Thromb Haemost. 2023 Sep;21(9):2311-2312.

24.Yasaka M, Yokota H, Suzuki M, Asakura H, Yamane T, Ogi Y, Kimoto T, Nakayama D

Idarucizumab for Emergency Reversal of the Anticoagulant Effects of Dabigatran: Final Results of a Japanese Postmarketing Surveillance Study
Cardiol Ther 12: 723-740. 2023

25.Yamazaki H, Iwata Y, Maekawa A, Azuma T, Shimano Y, Yokoyama T, Nakade J, Tanaka Y, Nakamura Y, Takahashi Y, Zaimoku Y, Oe H, Oshima M, Mori M, Gabata T.

A Japanese Case of COVID-19 Caused by Omicron Strain with Y453F Substitution      
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi. 2023 Dec 26;33(1):19-21.

26.Usuki K, Ohtake S, Honda S, Matsuda M, Wakita A, Nawa Y, Takase K, Maeda A, Sezaki N, Yokoyama H, Takada S, Hirano D, Tomikawa T, Sumi M, Yano S, Handa H, Ota S, Fujita H, Fujimaki K, Mugitani A, Kojima K, Kajiguchi T, Fujimoto K, Asou N, Usui N, Ishikawa Y, Katsumi A, Matsumura I, Kiyoi H, Miyazaki Y.

Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).
Int J Hematol. 119(1):24-38.  2024

27.Nakagawa N, Ishiyama K, Usuki K, Takada S, Tomikawa T, Handa H, Katsuoka Y, Hirano D, Sezaki N, Sumi M, Fujisawa S, Taniguchi Y, Mugitani A, Yoshimura T, Ohtsuka E, Takase K, Suehiro Y, Ota S, Kajiguchi T, Maeda T, Yamamoto M, Ohtake S, Katsumi A, Kiyoi H, Matsumura I, Miyazaki Y.

Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT.
Ann Hematol. 103(1):307-320. 2024

28.Togashi T, Nagaya S, Meguro-Horike M, Matsumoto H, Imai Y, Yamaguchi K, Fujii Y, Moriya H, Kikuchi Y, Yasuda I, Horike SI, Morishita E.

Identification of two de novo variants causing inherited antithrombin deficiency by quantitative analysis of variant alleles.
Thromb Res. 233:37-40 2024

29.Shingai N, Mizumaki H, Najima Y, Yamada Y, Tran DC, Haraguchi K, Toya T, Okuyama Y, Doki N, Nannya Y, Ogawa S, Nakao S

Immune pressure on hematopoietic stem cells can drastically expand glycosylphosphatidylinositol-deficient clones in paroxysmal nocturnal hemoglobinuria.
Front Immunol 14:1329403 2024

30.Hatakeyama K, Kikushige Y, Ishihara D, Yamamoto S, Kawano G, Tochigi T, Miyamoto T, Sakoda T, Christoforou A, Kunisaki Y, Fukata M, Kato K, Ito T, Handa H, Akashi K.
Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drugs-induced thromboembolism.
Blood Adv 8, 785-796, 2024


31.Kobayashi T, Sugiura K, Ojima T, Serizawa M, Hirai K, Morishita E

Thrombosis-related characteristics of pregnant women with antithrombin deficiency, protein C deficiency and protein S deficiency in Japan.
Thromb J.　8;22(1):18 2024

32.Usuki K, Ohtake S, Honda S, Matsuda M, Wakita A, Nawa Y, Takase K, Maeda A, Sezaki N, Yokoyama H, Takada S, Hirano D, Tomikawa T, Sumi M, Yano S, Handa H, Ota S, Fujita H, Fujimaki K, Mugitani A, Kojima K, Kajiguchi T, Fujimoto K, Asou N, Usui N, Ishikawa Y, Katsumi A, Matsumura I, Miyazaki Y, Kiyoi H.

Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).
Int J Hematol. 119(2):130-145. 2024

33.Horigome Y, Iino M, Harazaki Y, Kobayashi T, Handa H, Hiramatsu Y, Kuroi T, Tanimoto K, Matsue K, Abe M, Ishida T, Ito S, Iwasaki H, Kuroda J, Shibayama H, Sunami K, Takamatsu H, Tamura H, Hayashi T, Akagi K, Maeda T, Yoshida T, Mori I, Shinozaki T, Iida S.

A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan.
Ann Hematol.　103(2):475-488.  2024

34.Mitani K, Lee JW, Jang JH, Tomiyama Y, Miyazaki K, Nagafuji K, Usuki K, Uoshima N, Fujisaki T, Kosugi H, Matsumura I, Sasaki K, Kizaki M, Sawa M, Hidaka M, Kobayashi N, Ichikawa S, Yonemura Y, Murotani K, Shimizu M, Matsuda A, Ozawa K, Nakao S

Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study
Blood Adv 8:1415-1419 2024

35.Nakagawa SI, Nukii Y, Mochizuki K, Uchiyama A, Maeda Y, Kurokawa T.

A case of peripheral T-cell lymphoma in which therapy-related myelodysplastic syndrome developed and a second autologous transplantation was performed.
J Clin Exp Hematop. ;64(1):59-64.  2024

36.Morita K, Karashima S, Terao T, Yoshida K, Yamashita T, Yoroidaka T, Tanabe M, Imi T, Zaimoku Y, Yoshida A, Maruyama H, Iwaki N, Aoki G, Kotani T, Murata R, Miyamoto T, Machida Y, Matsue K, Nambo H, Takamatsu H.

D CNN-based Deep Learning Model-based Explanatory Prognostication in Patients with Multiple Myeloma using Whole-body MRI
J Med Syst. Mar 8;48(1):30 2024

37.Zaimoku Y, Katagiri T, Nakagawa N, Imi T, Maruyama H, Takamatsu H, Ishiyama K, Yamazaki H, Miyamoto T, Nakao S.

HLA Class I Allele Loss and Bone Marrow Transplantation Outcomes in Immune Aplastic Anemia.
Transplant Cell Ther.30(3):281.e1-e13. 2024

38.Nakagawa N, Fuji A, Ueda Y, Yamazaki M
Cryoglobulinemia vasculitis associated with adult-onset Still’s disease
Clinical Case Reports. Vol　12(3), e8632,  2024


39.Marumo A, Sugihara H, Omori I, Morishita E.
Relapse of Acquired Hemophilia A after COVID-19 Infection.
J Nippon Med Sch. 2024 Jan 20;90(6):474-479.


40.Nishikage S, Fujisawa A, Endoh H, Suzuki T, Kanzawa M, Ishii S, Okano M, Nitta E, Yakushijin K, Asakura H, Nozu K, Katayama Y, Nitta R, Sakaguchi K
Amyloid deposition through endocytosis in vascular endothelial cells
Exp Hematol. 2024 Jan;129:104129.

41.Sugihara H, Marumo A, Okabe H, Kohama K, Mera T, Morishita E

Platelet and large platelet ratios are useful in predicting severity of COVID-19.
Int J Hematol. 119: 638–646, 2024.

業績集（令和6年４月～令和7年3月）

 

Ⅰ　原　　　著

英文原著

1.Sugio T, Uchida N, Miyawaki K, Ohno Y, Eto T, Mori Y, Yoshimoto G, Kikushige Y, Kunisaki Y, Mizuno S, Nagafuji K, Iwasaki H, Kamimura T, Ogawa R, Miyamoto T, Taniguchi S, Akashi K, Kato K.

Prognostic impact of HLA supertype mismatch in single-unit cord blood transplantation.
Bone Marrow Transplant 59, 466-472, 2024

2.Mori Y, Takizawa J, Katsuoka Y, Takezako N, Nagafuji K, Handa H, Kuroda J, Sunami K, Kamimura T, Ogawa R, Kikushige Y, Harada M, Akashi K, Miyamoto T.

Autologous HSCT with novel agent-based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma.
Cancer Sci 115, 2002-2011, 2024

3.Kato K, Izutsu K, Nishikori M, Shibayama H, Maeda Y, Yoshimura K, Tateishi U, Miyamoto T, Matsuda Y, Ishikawa J, Rai S, Takahashi T, Yamauchi T, Matsumura I, Akashi K, Kanakura Y, Suzumiya J.

End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial.
Int J Hematol 119, 677-685, 2024

4.Usuki K, Miyamoto T, Yamauchi T, Ando K, Ogawa Y, Onozawa M, Yamauchi T, Kiyoi H, Yokota A, Ikezoe T, Katsuoka Y, Takada S, Aotsuka N, Morita Y, Ishikawa T, Asada N, Ota S, Dohi A, Morimoto K, Imai S, Kishimoto U, Akashi K, Miyazaki Y.

A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia
Int J Hematol 119, 647-659, 2024

5.Shima T, Minami M, Tochigi T, Kochi Y, Jinnouchi F, Yamauchi T, Mori Y, Yoshimoto G, Mizuno S, Miyamoto T, Kato K, Akashi K.

Procalcitonin elevation in febrile recipients during pre-transplant conditioning with anti-thymocyte globulin.
Blood Cell Ther 7, 49-55, 2024

6.Matsumura I, Ohtake S, Atsuta Y, Kurata M, Minami Y, Takahashi N, Nakaseko C, Iriyama N, Fujimaki K, Kakihana K, Ogasawara Y, Ono T, Okada M, Tauchi T, Miyamoto T, Ohnishi K, Sakaida E, Fujisawa S, Kobayashi Y, Asou N, Naoe T, Kiyoi H, Miyazaki Y.

Nilotinib vs. Dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 Study
Blood Adv 7, 49-55, 2024

7.Yamada S, Sakai K, Kubo M, Okumura H, Asakura H, Miyamoto T, Matsumoto M.

Excessive cleavage of von Willebrand factor multimers by ADAMTS13 may predict the progression of transplant-associated thrombotic microangiopathy.
Res Pract Thromb Haemost 7, 49-55, 2024

8.amamoto R, Hiramoto N, Fujimoto A, Yamazaki H, Mori T, Uchida N, Doki N, Kato J, Nishikubo M, Kako S, Nishida T, Ota S, Onizuka M, Eto T, Onodera K, Ikegame K, Matsuoka KI, Kanda Y, Fukuda T, Atsuta Y, Onishi Y.

Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation        
Bone Marrow Transplant ;59(5):688-691. 2024.5

9.Nakamura Y, Zaimoku Y, Yamaguchi H, Yamazaki H, Kanaya M, Uchida N, Doki N, Sakurai M, Hiramoto N, Kako S, Onizuka M, Onodera K, Maruyama Y, Ohigashi H, Nishida T, Yoshihara S, Matsuoka KI, Eto T, Kanda Y, Fukuda T, Atsuta Y, Onishi Y.

Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia
Ann Hematol. 2024 Aug;103(8):3121-3133..8(5):102517. 2024.8

10.Zaimoku Y, Sakai K, Tsuji N, Hosomichi K, Yamada S, Tran DC, Kobayashi M, Sugiyama A, Hirayasu K, Mizumaki H, Ishiyama K, Hanayama R, Tomiyama Y, Nakao S.

Haematopoietic regeneration by HLA-A*0206-deficient clones in severe aplastic anaemia without definitive immunosuppressive treatment　
Br J Haematol. 2024 Nov;205(5):1995-1999."2024.11

11.Katagiri T, Takahashi R, Zaimoku Y, Hosokawa K, Ogawa S, Takahashi Y, Miyamura T, Onishi Y, Koike T, Nishida T, Uchida N, Doki N, Tanaka M, Eto T, Itagaki M, Sawa M, Fukuda T, Onizuka M, Atsuta Y, Nakao S.

Frequent loss of HLA-B*40:02 from leucocytes in male patients with hepatitis-associated aplastic anaemia
Br J Haematol. 2024 Nov;205(5):2084-2088. 2024.11

12.Yamada S, Miyamoto T, Asakura H.
Distinguishing hyperfibrinolysis from enhanced-fibrinolytic-type disseminated intravascular coagulation.       
Res Pract Thromb Haemost.8(7):102574. 2024.9


13.Yamada S, Asakura H.
How We Interpret Thrombosis with Thrombocytopenia Syndrome?    Int J Mol Sci. 25(9):4956. 2024.5


14.Ishii A, Tsukamoto S, Mimura N, Miyamoto-Nagai Y, Isshiki Y, Matsui S, Nakao S, Shibamiya A, Hino Y, Kayamori K, Oshima-Hasegawa N, Muto T, Takeda Y, Suichi T, Misawa S, Ohwada C, Yokote K, Kuwabara S, Nakaseko C, Takamatsu H, Sakaida E.

Detection of clonal plasma cells in POEMS syndrome using multiparameter flow cytometry.
Sci Rep. 6;14(1):10362. 2024.5

15.Shibayama H, Itagaki M, Handa H, Yokoyama A, Saito A, Kosugi S, Ota S, Yoshimitsu M, Tanaka Y, Kurahashi S, Fuchida SI, Iino M, Shimizu T, Moriuchi Y, Toyama K, Mitani K, Tsukune Y, Kada A, Tamura H, Abe M, Iwasaki H, Kuroda J, Takamatsu H, Sunami K, Kizaki M, Ishida T, Saito T, Matsumura I, Akashi K, Iida S.

Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016-2021).    
Int J Hematol. 119(6):707-721. 2024 .6

16.Kogure Y, Handa H, Ito Y, Ri M, Horigome Y, Iino M, Harazaki Y, Kobayashi T, Abe M, Ishida T, Ito S, Iwasaki H, Kuroda J, Shibayama H, Sunami K, Takamatsu H, Tamura H, Hayashi T, Akagi K, Shinozaki T, Yoshida T, Mori I, Iida S, Maeda T, Kataoka K.

ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone.
Blood. 6;143(23):2401-2413. 2024 .6

17.Sakai T, Ueda Y, Yanagisawa H, Arita K, Iwao H, Yamada K, Mizuta S, Kawabata H, Fukushima T, Tai K, Kishi S, Morinaga K, Murakami J, Takamatsu H, Terasaki Y, Yoshio N, Kondo Y, Okumura H, Matano S, Yamaguchi M, Tsutani H, Masaki Y.

Prospective therapeutic studies of disseminated extranodal large B-cell lymphoma including intravascular large B-cell lymphoma.
Global Health & Medicine.  25;11:100010. 2024.4

18.Garderet L, Gras L, Koster L, Baaij L, Hamad N, Dsouza A, Estrada-Merly N, Hari P, Saber W, Cowan AJ, Iida M, Okamoto S, Takamatsu H, Mizuno S, Kawamura K, Kodera Y, Ko BS, Liam C, HO KW, Goh AS, Tan SK, Elhaddad AM, Bazarbachi A, Chaudhry QN, Alfar R, Bekadja MA, Benakli M, Frutos Ortiz CA, Riva E, Galeano S, Bass F, Mian HS, McCurdy A, Wang FR, Meng L, Neumann D, Koh M, Snowden JA, Schönland S, McLornan DP, Hayden PJ, Sureda A, Greinix HT, Aljurf M, Atsuta Y, Niederwieser D.

Global Characteristics and Outcomes of Autologous Hematopoietic Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: A Study of The Worldwide Network for Blood and Marrow Transplantation (WBMT).
American Journal of Hematology. 99(11):2084-2095. 2024.11

19.Tagami N, Ishida T, Takamatsu H, Shirai H.

Physician survey on the measurement of minimal residual disease in individuals with multiple myeloma.
International Journal of Myeloma 14(6): 53–61, 2024.

20.Fujii Y, Nagaya S, Seo A, Kanazawa Y, Oba T, Morishita E

Effect of Antithrombin Leakage From Hemodialysis Therapy on Antithrombin Hemodynamics.
Cureus 2024.12

21.Togashi T, Baatartsogt N, Nagao Y, Kashiwakura Y, Hayakawa M, Hiramoto T, Fujiwara T, Morishita E, Nureki O, Ohmori T

Cure of Congenital Purpura Fulminans via Expression of Engineered Protein C Through Neonatal Genome Editing in Mice.
Arterioscler Thromb Vasc Biol. 44(12):2616-2627. 2024.11

22.Shimonishi N, Morishita E, Ogiwara K, Maruyama K, Yoshida J, Horie K, Nogami K

A novel factor V compound heterozygous mutation associated with thrombosis (Y1961C; FV-Kanazawa, together with 1982_1983del). 
J Thromb Haemost. 22(10):2810-2822. 2024.10

23.Nishiwaki S, Sugiura I, Fujisawa S, Hatta Y, Atsuta Y, Doki N, Kurahashi S, Ueda Y, Dobashi N, Maeda T, Matsumura I, Tanaka M, Kako S, Ichinohe T, Fukuda T, Ohtake S, Ishikawa Y, Miyazaki Y, Kiyoi H; Japan Adult Leukemia Study Group.

Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete　molecular remission.
Am J Hematol. 99(5):806-815. 2024.5

24.Kaneda Y,Fukuno K, Minami H, Nonaka Y, Horinoue A, Kuroki Y, Osaki T, Souri M, Asakura H, Ichinose A

Autoimmune acquired coagulation factor V deficiency with hyperfibrinolytic disseminated intravascular coagulation  
Int J Lab Hematol 46: 395-399. 2024.4

25.Sawa M, Miyamoto T, Kim HJ, Hiramatsu Y, Cheong JW, Ikezoe T, Naoe T, Akashi K, Morita S, Kosako M, Ikegaya M, Terada W, Kadokura T, Hill J, Miyawaki S, Gill SC, Heinloth A, Hasabou N.

A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia.
Int J Hematol 121, 56-67, 2025


26.Sakoda T, Kikushige Y, Irifune H, Kawano G, Harada T, Semba Y, Hayashi M, Shima T, Mori Y, Eto T, Kamimura T, Iwasaki H, Ogawa R, Yoshimoto G, Kato K, Maeda T, Miyamoto T, Akashi K.

TIM-3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation.
Cancer Sci 116, 698-709, 2025.

27.Takahashi Y, Nakade J, Zaimoku Y, Watanabe N, Watari T, Otsuka Y, Iwata Y, Kanamori H.

Culture-negative infective endocarditis due to Neisseria bacilliformis identified via 16S rRNA gene analysis from resected valve tissue: Case report and review of the literature
J Infect Chemother. 2025 Feb;31(2):102502  2025.2

28.Lundgren S, Huuhtanen J, Keränen M, Feng X, Patel BA, Ryland GL, Fox LC, Bravo-Perez C, Clemente M, Kerr C, Walldin G, Dufva O, Zaimoku Y, Tuononen T, Myllymäki M, Ebeling F, Jokinen E, Heinonen M, Kasanen T, Klievink J, Lähteenmäki H, Jaatinen T, Kytölä S, Siitonen S, Dulau-Florea A, Braylan R, Heinäniemi M, Nakao S, Hellström-Lindberg E, Maciejewski JP, Blombery P, Young NS, Lähdesmäki H, Mustjoki S.

Single-cell analysis of aplastic anemia reveals a convergence of NK and NK-like CD8+ T cells with a disease-associated TCR signature
Sci Transl Med. 2025 Feb 26;17(787):eadl6758     2025.2  
 

29.Fujii Y, Nagaya S, Kanno T, Yamada S, Suzuki M, Goto K, Horiuchi H, Matsumoto M, Morishita E

Loss of von Willebrand factor large multimers in patients undergoing hemodialysis: A single-center, retrospective study.
Thromb Res.249:109316. 2025.3

30.Kamikubo Y, Nagaya S, Inoue R, Yamaguchi K, Morimoto-Kamata R, Inoue K, Morishita E, Samad F, Ohkura N

Tissue Factor Pathway-Driven Initial Thrombin Generation is Associated with Hypercoagulability in Obesity.
Thromb Haemost. doi: 10.1055/a-2552-2050. 2025.3

31.Kikuchi Y, Nagaya S, Togashi T, Imai Y, Togashi M, Araiso Y, Nishiuchi T, Morishita E

Mechanism of antithrombin deficiency due to the novel variant C32W in the C-terminus of the signal peptide.
Int J Hematol. doi: 10.1007/s12185-025-03945-x.  2025.2

32.Yui R, Nagaya S, Yasuda I, Togashi T, Kikuchi Y, Saito K, Meguro-Horike M, Horike SI, Kawasaki H, Nishikii H, Morishita E

The novel protein C variant p.C101F results in early intracellular degradation that drives type I protein C deficiency
Int J Hematol. doi: 10.1007/s12185-025-03943-z.  2025.2

33.Jo T, Yoshihara K, Ri M, Tsukada N, Mimura N, Fujii K, Fukushima K, Fujiwara S, Shimura Y, Haraguchi K, Kato K, Satake A, Yoshida A, Suzuki R, Ikemoto J, Iwaki K, Takeda W, Yonetani N, Tanosaki R, Yamada-Fujiwara M, Kahata K, Nagamura-Inoue T, Yoshihara S, Arai Y

Low platelet counts and low CD4/CD8 ratios at apheresis increase the risk of CAR T-cell manufacturing failure in myeloma
Blood Neoplasia (2025) 2 (1): 100051. 2025. 2  

34.Hasegawa G, Nakagawa N, Ueda Y, Yamazaki M

Retreatment with brentuximab vedotin for discordant peripheral T-cell lymphomas
Leukemia Research Reports Volume 23, 2025.1